Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.750
+0.100 (2.15%)
At close: Jan 12, 2026
Veradigm Market Cap
Veradigm has a market cap or net worth of $807.56 million as of January 13, 2026. Its market cap has decreased by -49.87% in one year.
Market Cap
807.56M
Enterprise Value
580.41M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.75
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 807.56M, an increase of 158.98%. That is a compound annual growth rate of 5.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 807.56M | -1.03% |
| Dec 31, 2025 | 815.97M | -50.64% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 711.87M |
| Elite Pharmaceuticals | 521.08M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 343.01M |
| Silence Therapeutics | 260.73M |
| OpGen | 180.66M |